Operating Lease, Right-of-Use Asset of BioCardia, Inc. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
BioCardia, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • BioCardia, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $599,000, a 40% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

BioCardia, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $599,000 -$394,000 -40% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $702,000 -$383,000 -35% 30 Jun 2025 10-Q/A 29 Oct 2025 2025 Q2
Q1 2025 $801,000 -$373,000 -32% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $898,000 -$363,000 -29% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $993,000 -$353,000 -26% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 $1,085,000 -$344,000 -24% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 $1,174,000 -$335,000 -22% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 $1,261,000 -$327,000 -21% 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 $1,346,000 -$318,000 -19% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $1,429,000 -$310,000 -18% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $1,509,000 -$303,000 -17% 31 Mar 2023 10-Q 10 May 2023 2023 Q1
Q4 2022 $1,588,000 -$295,000 -16% 31 Dec 2022 10-K 27 Mar 2024 2023 FY
Q3 2022 $1,664,000 +$1,515,000 +1017% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $1,739,000 +$1,446,000 +494% 30 Jun 2022 10-Q 10 Aug 2022 2022 Q2
Q1 2022 $1,812,000 +$1,380,000 +319% 31 Mar 2022 10-Q 11 May 2022 2022 Q1
Q4 2021 $1,883,000 +$1,316,000 +232% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $149,000 -$548,000 -79% 30 Sep 2021 10-Q 10 Nov 2021 2021 Q3
Q2 2021 $293,000 -$531,000 -64% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $432,000 -$515,000 -54% 31 Mar 2021 10-Q 13 May 2021 2021 Q1
Q4 2020 $567,000 -$498,000 -47% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 $697,000 -$483,000 -41% 30 Sep 2020 10-Q 10 Nov 2020 2020 Q3
Q2 2020 $824,000 -$468,000 -36% 30 Jun 2020 10-Q 13 Aug 2020 2020 Q2
Q1 2020 $947,000 -$453,000 -32% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 $1,065,000 -$440,000 -29% 31 Dec 2019 10-K 30 Mar 2021 2020 FY
Q3 2019 $1,180,000 30 Sep 2019 10-Q 19 Nov 2019 2019 Q3
Q2 2019 $1,292,000 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 $1,400,000 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 $1,505,000 01 Jan 2019 10-Q 19 Nov 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.